Canalys:西欧首季PC出货量升48%至1,610万台
调查机构Canalys发表的报告指,首季西欧PC出货量达1,610万台,按年升48%,认为疫情带来的需求延续至2021年,虽然主要零部件均出现瓶颈致部分订单延迟,不过供应链情况较去年首季明显改善,当时受疫情爆发影响厂房需突然关闭。
按品牌划分,期内HP(HPQ.US)出货量达410.6万台,按年增长32%,市占率26%排名第一,联想(00992.HK)出货量则升29%至402.9万台,市占排第二,排名第三及第四的Dell(DELL.US)及苹果(AAPL.US)出货量分别按年增长31%及127%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.